FIELD: medicine, pharmaceutics.
SUBSTANCE: group of inventions refers to medicine and aims at cell protection against the cytopathogenic action of hepatitis C virus. What is declared is a pharmaceutical composition possessing antiviral action on hepatitis C virus and a method for preparing it. The chicken broiler's head is electrically stimulated in a mode of 100-120 V 3-4 A for 3-4 s. The blood is sampled and incubated at 4-8°C for 18-24 hours. The serum is sampled. The sampled serum is filtered through a filter of a pore size of 10 nm, lyophilised and irradiated in a line electron accelerator (LEA) in a mode of 10-40 kGy.
EFFECT: using the declared group of inventions is effective for cell protection against the cytopathogenic action of hepatitis C virus.
2 cl, 2 tbl, 1 ex
Title | Year | Author | Number |
---|---|---|---|
PHARMACEUTICAL COMPOSITION AND METHOD OF OBTAINING ANTIONCOLOGIC FRACTIONS OF BLOOD SERUM (AF BS) | 2009 |
|
RU2426548C2 |
BIOTREATMENT BLOOD SERUM, METHODS OF PRODUCTION AND APPLICATION | 2004 |
|
RU2364404C2 |
ANTIVIRAL AGENT | 2014 |
|
RU2564919C1 |
METHOD OF TREATING VIRAL HEPATITIS C | 2012 |
|
RU2496512C1 |
CYCLOHEXANOXYCARBONYL-DIPEPTIDE AND ITS ANTIVIRAL ACTIVITY AGAINST HEPATITIS C VIRUS | 2017 |
|
RU2641297C1 |
PEPTIDE DERIVATIVES OF 1-(1-ADAMANTYL)ETHYLAMINE AND THEIR ANTIVIRAL ACTION | 2013 |
|
RU2524216C1 |
MEDICATION FOR REDUCTION OF HEPATITIS C VIRUS REPRODUCTION | 2013 |
|
RU2526179C1 |
ANTIVIRAL COMPOSITION | 2018 |
|
RU2697886C1 |
AGENT FOR TREATMENT OF VIRAL HEPATITIS C | 2003 |
|
RU2244554C1 |
AGENT FOR VIRUS DISEASES PREVENTION AND TREATMENT AND METHOD OF VIRUS DISEASES PREVENTION AND TREATMENT | 2007 |
|
RU2337703C1 |
Authors
Dates
2014-08-27—Published
2012-09-06—Filed